MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Innoventus Project AB

Innoventus Project AB
Innoventus Project AB acquires, develops, finances and commercializes life science projects based on ideas from academic scientists for divestment to industrial companies.

The company in detail

Summary

The company was founded in 1999 as Innoventus Uppsala Life Science. Innoventus is a bioscience project development company that works with researchers and industry partners to commercialise ideas. By forging strategic relationships with industry partners, Innoventus moves scientific ideas toward commercial product marketability. Innoventus' exit strategy is to attract industrial and venture capital.

R&D

To view this information, you must subscribe to PL Intelligence.

Senior management

To view this information, you must subscribe to PL Intelligence.

Board of directors

To view this information, you must subscribe to PL Intelligence.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Pharmalicensing Jobs
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us